On December 28, the first domestically developed oral trivalent reassortant rotavirus attenuated live vaccine (Vero cells) produced by China National Pharmaceutical Group Corporation (Sinopharm) Lanzhou Institute of Biological Products received the approval and issuance certificate from the China Food and Drug Inspection Research Institute. The vaccine has been sent to various regions across the country and is about to commence vaccination.

Rotavirus is a major cause of severe acute diarrhea in infants and young children, with almost every child under the age of 5 being infected at least once. If not intervened in a timely manner, it may lead to systemic damage affecting respiratory, circulatory, and central nervous systems, and in severe cases, dehydration, shock, and even death. Both the World Health Organization (WHO) position papers and the 'Expert Consensus on Immunization Prevention of Rotavirus Gastroenteritis in Children' released in China in 2020 clearly state that vaccination with rotavirus vaccines is the most cost-effective way to prevent rotavirus-related diarrhea and is an effective means of reducing the incidence and mortality of diarrhea in infants and young children.

As the cradle of rotavirus vaccine production, Lanzhou Institute of Biological Products has been a pioneer since 2001 when China's first rotavirus attenuated live vaccine was successfully launched in the country, with an accumulated usage exceeding 100 million doses to date. The latest independently developed trivalent rotavirus vaccine represents the dedication of several generations. Whether it is the oral rotavirus live vaccine (RotaTeq) widely used in the market or the trivalent reassortant rotavirus attenuated live vaccine (RotaWei) approved for market launch in 2023, the goal is to protect the health and lives of infants and young children.

As the exclusive producer and supplier of the two rotavirus vaccines in China, Sinopharm Lanzhou Institute of Biological Products is also the cradle of rotavirus vaccines in China. The successful launch of these two rotavirus vaccines provides robust health security for the protection and healthy growth of our country's children.

https://mp.weixin.qq.com/s/rX9EHiUmZLy9L2fBJZv_1Q